Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 07:49 PM EDT
Outlook Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | 21.12M | -46.81M | -75.37M | -94.05M | -159.13M | -51.5M | -58.98M | -60.34M | -57.2M | -70.25M | -66.05M | -65.11M | -59.77M | -53.17M | -53.16M | -49.68M | -40.5M | -33.09M |
Depreciation & Amortization | 115.37K | 114.47K | 113.86K | 96.28K | 78.8K | 61.6K | 44.19K | 84.44K | 21.98K | -40.11K | -18 | -814 | 98.64K | 231.89K | 262.14K | 291.62K | 365.73K | 459.84K |
Stock-Based Compensation | 8.2M | 7.78M | 5.39M | 5.37M | 5.35M | 5.43M | 5.55M | 5.53M | 5.52M | 7.9M | 7.71M | 7.74M | 7.57M | 4.94M | 4.89M | 4.27M | 4.43M | 3.6M |
Other Working Capital | 3.2M | 2.47M | -4.41M | -9.85M | -4.44M | -5.22M | 1.67M | 6.62M | 786.15K | 2.06M | -2.98M | -785.83K | -3.35M | -5.57M | -6.88M | -10.8M | -3.48M | -1.61M |
Other Non-Cash Items | -96.89M | -35.89M | 4.04M | 33.23M | 99.7M | 4.76M | 5.66M | 5.26M | 4.31M | 8.87M | 7.48M | 7.28M | 5.56M | 1.43M | 341.55K | -22.45K | 509.23K | -1.55M |
Deferred Income Tax | n/a | n/a | 50.79K | 31.86K | 50.79K | 50.79K | n/a | 18.94K | -1.27M | -4.93M | -4.13M | -4.43M | -2.7M | 1.19M | 498.49K | 798.82K | -5.6M | -5.4M |
Change in Working Capital | 3.41M | 8.07M | -3.02M | -9.23M | -4.31M | -5.91M | 4.75M | 8.96M | 245.91K | 3.87M | -1.68M | -893.8K | -5.27M | -6.54M | -7.08M | -13M | -2.31M | -2.45M |
Operating Cash Flow | -64.05M | -66.73M | -68.79M | -64.55M | -58.26M | -47.1M | -42.97M | -40.48M | -48.37M | -54.59M | -56.67M | -55.41M | -54.51M | -51.92M | -54.25M | -57.34M | -43.1M | -38.44M |
Capital Expenditures | -2 | -8 | -3 | -2 | 1.00 | 4.00 | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 900K | n/a | n/a |
Investing Cash Flow | 6.00 | 3.00 | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 900K | n/a | n/a |
Debt Repayment | 194.24K | 3.18K | n/a | -7.35K | -10.33K | -12.14K | 19.77M | 19.77M | 8.17M | 7.87M | -2.32M | -2.33M | 9.24M | 9.53M | 6.31M | 6.3M | 7.19M | 7.07M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -166.13B | -166.13B | -166.13B |
Other Financial Acitivies | 16.83M | -4.27K | -4.27K | n/a | n/a | -254.96K | -823.89K | -823.89K | -823.89K | -380.83K | -394.15K | -386.58K | -386.58K | 3.01M | 3.59M | 3.58M | 3.58M | 1.07M |
Financial Cash Flow | 24.37M | 62.07M | 60.33M | 62.87M | 61.86M | 5.12M | 48.97M | 48.17M | 33.57M | 36.78M | 59.59M | 61.74M | 75.76M | 116.5M | 56.19M | 53.08M | 76.52M | 43.58M |
Net Cash Flow | -39.67M | -4.65M | -8.46M | -1.68M | 3.6M | -41.98M | 6M | 7.69M | -14.79M | -17.81M | 2.92M | 6.33M | 21.26M | 64.58M | 1.94M | -4.26M | 32.52M | 4.23M |
Free Cash Flow | -64.05M | -66.73M | -68.79M | -64.55M | -58.26M | -47.1M | -42.97M | -40.48M | -48.37M | -54.59M | -56.67M | -55.41M | -54.51M | -51.92M | -54.25M | -57.34M | -43.1M | -38.44M |